𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia

✍ Scribed by Anita Schmitt; Peter Reinhardt; Iwona Hus; Jacek Tabarkiewicz; Jacek Roliñski; Thomas Barth; Krzysztof Giannopoulos; Anna Dmoszyñska; Markus Wiesneth; Michael Schmitt


Book ID
109143715
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
188 KB
Volume
47
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Immunotherapy using autologous monocyte-
✍ Je-Jung Lee; Hoon Kook; Myong-Suk Park; Jong-Hee Nam; Bo-Hwa Choi; Won-Hyun Song 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Although a second stem cell transplantation (SCT) can be used as salvage therapy in patients with relapsing leukemia after SCT, most of these patients have a poor outcome. We tried clinical vaccination using monocyte-derived dendritic cells (DCs) pulsed with leukemic lysates to treat relapsing acute

Optimization of the concentration of aut
✍ Bo-Hwa Choi; Hyun-Kyu Kang; Jung-Sun Park; Sang-Ki Kim; Than-Nhan Nguyen Pham; X 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Clinical application of immunotherapy for acute myeloid leukemia (AML) requires the efficient induction of dendritic cells (DCs) from AML blast cells using in vitro culture. We examined the effect of autologous serum on the properties of leukemic DCs derived from leukemic cells of AML patients by cu

mRNA expression of leukemia-associated a
✍ Jochen Greiner; Mark Ringhoffer; Masanori Taniguchi; Li Li; Anita Schmitt; Hiros 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemia‐associated antigens (LAA) as target structures might be a therapeutic option to enhance the graft‐__vs__.‐leukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r